Thyroid Cancer
Conditions
Interventions
Group B (Unilateral lobectomy and/or ipsilateral central lymph node dissection):NA
Group A (Total thyroidectomy and/or central lymph node dissection):NA
Sponsors
Peking University International Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Pathologically confirmed TNM stage T1-2 papillary thyroid carcinoma with coexisting Hashimoto's disease; 2) Underwent standard radical surgery for thyroid cancer; 3) Patients underwent limited surgical intervention.
Exclusion criteria
Exclusion criteria: 1) Presenting with distant metastasis; 2) The histopathological findings include follicular carcinoma, medullary carcinoma, poorly differentiated carcinoma, or undifferentiated carcinoma; 3) Coexisting with diffuse toxic goiter, acute suppurative thyroiditis, or subacute thyroiditis; 4) Patients who initially underwent regular follow-up surveillance and/or interventions such as radiofrequency ablation or intra-iodine-131 radiation therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease Free Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative hospital stay;Surgery time;Amount of bleeding; | — |
Countries
China
Contacts
Public ContactDongdong Zhang
Peking University International Hospital
Outcome results
None listed